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FOREWORD 
The Scientific Committee for AnimaL Nutrition was set up by Commission Decision 76/791/EEC of 
24 September 1976 (OJ No L 279 of 9.10.1976, p. 35) in order to provide the Commission with 
informed opinions on matters reLating to animal nutrition and stock farming and the effects of 
production techniques on food quality and the environment. 
The Members of the Committee are independent persons, highly-qualified in the fields associated 
with animal nutrition, biology, pharmacology, toxicology, medicine, veterinary medicine and 
the environmental sciences. The Secretariat of the Committee is provided by the Commission's 
Directorate-General for Agriculture. 
The Committee's first series of reports, published in this volume, includes opinions relating 
principally to the safe use of antibiotics, coccidiostats and other medicinal substances in 
animal feed for collective prophylaxis, and on the effects of the presence of certain contami-
nants in animal feed. Questions in this connection had arisen in the course of the Commission's 
work on the approximation of Member States' laws on additives and undesirable substances in 
feedingstuffs. The detailed opinions drawn up by the Committee have removed much of the uncer-
tainty which threatened to hold up the preparation of proposals on the use of these substances 
in animal feed. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF NITROFURANS IN FEEDINGSTUFFS 
Opinion expressed 5 October 1977 
TERMS OF REFERENCE 
The Scientific Committee for Animal Nutrition was requested to give an opinion on the follow-
ing questions concerning furazolidone, nitrofurazone and bifuran (furazolidone + nitro-
furazone): 
1. Have carcinogenic or mutagenic effects been noted in experiments with these products ? 
2. Does the use of these products as additives in feedingstuffs result in the presence of 
residues in products of animal origin ? If so, what are the nature and quantities of such 
residues ? Could these residues be harmful to the consumer ? 
3. Are there any differences in purity of marketed products ? 
4. Are data available to make it possible to establish that use of the products as cocci-
diostats is no longer economic in livestock production ? 
5. In view of the answers to the abovementioned questions should 
- use of the products concerned as additives in feedingstuffs be prohibited in Member 
States ? 
- use be restricted to certain animal species under specific conditions ? 
BACKGROUND 
In accordance with the provisions of Council Directive 70/524/EEC (1), of 23 November 1970, 
concerning additives in feedingstuffs, as last amended by the nineteenth Commission Directive 
of 26 July 1977 (2), Member States are authorized to use, by way of derogation up to 
31 December 1977, furazolidone, nitrofurazone and bifuran (furazolidone + nitrofurazone) as 
additives in feedingstuff s. These products are listed in Annex II, Section B, of the 
directive without specific conditions of use. 
A recent examination of the use of these products has revealed numerous uncertainties as re-
gards compliance with the fundamental principles governing Community approval of additives, 
as laid down in Article 6 of the Directive. The Commission, therefore, considered it as 
necessary to seek the Opinion of the Scientific Committee for Animal Nutrition on the 
unresolved questions relating to these products. 
(1) 0J Nr L 270 of 14.12.1970, p. 1 
(2) 0J nr L 207 of 13.8.1977, p. 53 
OPINION OF THE COMMITTEE 
The Committee has examined the available data on the use of furazolidone, nitrofurazone and 
bifuran in animal nutrition and has identified numerous gaps in knowledge concerning methods 
of analysis, metabolism, carcinogenecity and mutagenecity. The information on nitrofurazone 
and bifuran appeared particularly deficient. The replies to the Commission's questions are 
set out below : 
1. Carcinogenic, mutagenic and teratogenic activity has been observed in laboratory animals. 
Additional data on these effects is necessary, particularly "dose/effect" relationships. 
2. These products, whose molecules are unstable, give rise to residues which are difficult to 
assess qualitatively and quantitavely given the lack of specificity and sensitivity of the 
existing methods. It is likely that certain of the metabolites formed are not detected 
by analysis. It would be desirable to study the effects of these residues by the method 
of relay toxicity. 
3. In addition to the substances originally authorized, products of various origins are being 
marketed without any guarantee as to purity criteria required by national pharmacopeas. 
These constitute a further risk factor. In this regard the Committee wishes, as a general 
rule, that marketed additives be warranted with respect to purity and amount of impurities. 
4. It has been established that the nitrofurans concerned have favourable coccidiostatic 
effects in some instances. 
5. In view of these considerations, the Committee feels that, in the absence of additional 
data, the use of furazolidone, nitrofurazone and bifuran as additives in feedingstuffs 
should be prohibited in the Community. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF NITROIMIDAZOLE DERIVATIVES IN FEEDINGSTUFFS 
Opinion expressed 8 December 1977 
Terms of reference 
The Scientific Committee for Animal Nutrition was requested to give an opinion on the follow-
ing questions concerning dimetridazole, ronidazole and ipronidazole : 
1. Have carcinogenic or mutagenic effects been noted in experiments with these products ? 
2. Does the use of these products as additives in feedingstuffs result in the presence of 
residues under the authorized conditions of use ? Could these residues be harmful to the 
consumer ? 
3. In view of the answers to the abovementioned questions, should 
- use as additives in feedingstuffs of the products concerned or of some of them be 
prohibited in Member States ? 
- their conditions of use be modified ? 
BACKGROUND 
In accordance with the provisions of Council Directive 70/524/EEC (1), of 23 November 1970, 
concerning additives in feedingstuffs, as last amended by the nineteenth Commission Directive 
of 26 July 1977 (2), the use of dimetridazole is authorized at Community level under the 
following conditions set out in Annex I, Section D, of the Directive : 
Species of animal : turkeys, guinea fowl. 
Minimum and maximum content in complete feedingstuffs : 125 - 150 ppm (mg/kg). 
Other provisions : use prohibited from laying age onwards and at least 3 days before slaughter 
respectively. 
Furthermore, Member States are authorized to use, by way of derogation up to 31 December 1977, 
dimetridazole for animal species other than turkeys and guinea fowl, ronidazole and iproni-
dazole. These provisions are set out in Annex II, Section B, of the Directive without specific 
conditions of use for dimetridazole and ronidazole and under the following conditions for 
ipronidazole : 
Species of animal : turkeys 
Minimum and maximum content in complete feedingstuffs : 5 0 - 8 5 ppm (mg/kg). 
Other provisions : use prohibited at least 5 days before slaughter. 
(1) 0J No L 270 of 14.12.1970, p. 1 
(2) 0J No L 207 of 13.8.1977, p. 53 
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In pursuance of this derogation, some Member States have authorized the use of dimetridazole 
in feedingstuffs for swine at levels of 100 to 150 ppm (mg/kg) with a withdrawal period vary-
ing between 3 to 5 days, the use of ronidazole in feedingstuffs for turkeys at levels of 50 
to 60 ppm (mg/kg) and for swine at 30 to 90 ppm (mg/kg) with a withdrawal period varying be-
tween 3 to 5 days, and that of ipronidazole under the conditions laid down in the Directive. 
A recent examination of these additives has revealed some uncertainties as regards the safety 
of their use in animal feeding. The Commission, therefore, considered it as necessary to 
seek the Opinion of the Scientific Committee for Animal Nutrition. 
OPINION OF THE COMMITTEE 
1. An increase in the number of benign and malignant mammary tumours and also mutagenic effects 
were observed in laboratory animals, in particular in rats, to which high doses of dimetri-
dazole, ronidazole and ipronidazole were administered orally over their lifetime. 
2. The sensitivity and specificity of analytical methods and also knowledge of the metabolism 
of these products enable a precise evaluation of their residues to be made. These are 
made up of the initial compound and oxidation products, which undergo rapid breakdown in 
animal products after withdrawal of the additive in the diet. Under the conditions of use 
at present authorized for these additives and, in particular, withdrawal periods varying 
between 3 to 5 days, it may be stated that, at the lower limit of analytical determination 
(0.002 mg/kg), there are no significant residues in the edible products (see Table in 
Annex). Possible traces in muscle or skin are broken down through cooking and during cold 
storage. 
3. The Committee is of the opinion that there is no reason to prohibit the use of dimetrida-
zole, ronidazole or ipronidazole as additives in feedingstuffs. 
Taking into account the similarity of their metabolism, the Committee considers however 
that withdrawal periods before slaughter should be standardized in order, with an addi-
tional safety factor, to ensure the absence of residues in products of animal origin. To 
this effect, a withdrawal period of at least 6 days is recommended for each of these 
addi t i ves. 
On this condition and account being taken of their efficacy for the various animal species, 
minimum and maximum dose-levels in mg/kg complete feedingstuff s should not exceed the 
following limits : 
Feedingstuffs for turkeys 
Feedingstuffs for guinea 
fowl 
Feedingstuffs for swine 
Dimetridazole 
100-200 
100-150 
100-200 
Ronidazole 
50-60 
-
60-90 
Ipronidazole 
50-100 
50-100 
-
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ANNEX 
Comparison of data from rearing practice and the study of residues in meat derived from 
animals consuming nutritional doses of nitroimidazole derivatives 
Additives 
Dimetridazole 
Ipronidazole 
Ronidazole 
Practical conditions of use 
Species of 
animal 
Turkeys 
Guinea fowl 
Swine 
Turkeys 
Guinea fowl 
Turkeys 
Swine 
Dose-level 
(mg/kg feed) 
100 - 200 
125 - 150 
100 - 150 
50 - 100 
50 - 100 
50 - 60 
30 - 90 
Duration 
of use 
(weeks) 
12 
10 
16 
12 
10 
12 
16 
Residues in 
meat(a)(b) 
(mg/kg) 
<0.002 
<0.002 
<0.002 
<0.002 
<0.002 
<0.002 
<0.002 
(a) After a withdrawal period of 6 days 
(b) Lower limit of analytical determination : 0.002 mg/kg. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF MACROLIDES AND RELATED PRODUCTS IN FEEDINGSTUFFS 
Opinion expressed 8 December 1977 
TERMS OF REFERENCE 
The Scientific Committee for Animal Nutrition was requested to examine the problems of 
bacterial resistance raised by the use of macrolides and related products and to give an 
opinion on the following questions : 
1. What are the possibilities of induction of resistances, cross-resistances or transfer of 
resistances which might result from the use as additives in feedingstuffs of the following 
antibiotics authorized by Community Directives : 
- oleandomycin 
- spiramycin 
- erythromycin 
- tylosin 
- lincomycin 
- vi rginiamycin ? 
2. Is data available that makes it possible to establish that, under the conditions of use 
authorized by Community Directives, the use for nutritional purposes of one or several of 
these antibiotics is no longer of interest in livestock rearing ? 
3. To what extent and for what purpose are these additives used in human or veterinary 
therapeutics ? 
4. Is the use of these products for nutritional purposes likely to interfere with their appli-
cation for therapeutic purposes ? 
5. In view of the answers to the abovementioned questions, should : 
- use as additives in feedingstuffs of the products concerned or of some of them be 
prohibited in Member States ? 
- their conditions of use be modified ? 
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BACKGROUND 
In accordance with the provisions of Council Directive 70/524/EEC (1), of 23 November 1970, 
concerning additives in feedingstuff s, as last amended by the twentieth Commission Directive 
of 7 December 1977 (2), the use of oleandomycin, spiramycin and virginiamycin is authorized 
at Community level under the following conditions set out in Annex I, Section A, of the 
Directive. In this regard, a derogation authorizing Denmark, Ireland and the United Kingdom 
to maintain in force until 31 December 1977 provisions of national law existing at the date 
of accession was granted according to the Acts of Accession of these countries to the European 
Community (3). 
Additive 
Oleandomycin 
Spiramycin 
Vi rginiamycin 
Species of animal 
Turkeys 
Other poultry, with the 
exception of ducks, 
geese, laying hens and 
pigeons 
Swine 
Turkeys 
Other poultry, with the 
exception of ducks, 
geese, laying hens and 
pigeons 
Swine, calves, lambs 
and kids 
Animals bred for fur 
Turkeys 
Other poultry, with the 
exception of ducks, 
geese, laying hens and 
pigeons 
Swine 
Calves 
Maximum age 
26 weeks 
16 weeks 
6 months 
26 weeks 
16 weeks 
6 months 
26 weeks 
16 weeks 
6 months 
6 months 
Minimum 
content 
Maximum 
content 
ppm (mg/kg) of complete 
feedingstuffs 
2 
2 
2 
5 
5 
5 
5 
5 
5 
5 
5 
10 
10 
10 
20 
20 
20 
80 (*) 
20 
20 
20 
20 
20 
80 (*) 
(*) Mi Lk replacers 
(1) 0J No L 270 of 14.12.1970, p. 1 
(2) 0J No L 18 of 24.1.1978, p. 7 
(3) OJ No L 73 of 27.3.1972, p.136 
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Furthermore, Member States are authorized to use, by way of derogation up to 31 December 1978, 
erythromycin, tylosin, lincomycin, oleandomycin, spiramycin and virginiamycin under the 
following conditions set out in Annex II, Section A, of the Directive. 
Additive 
Erythromycin 
Tylosin 
Lincomycin 
Oleandomycin 
Spiramycin 
Virginiamycin 
Species of animal 
Chickens for fattening 
Swine 
Swine 
Poultry, with the 
exception of ducks, geese 
and laying hens 
Poultry, with the 
exception of ducks and 
geese 
Swine 
Poultry, with the 
exception of ducks and 
geese 
Swine 
Calves, lambs and kids 
Animals bred for fur 
Poultry, with the 
exception of ducks and 
geese 
Swine 
Calves 
Maximum age 
2 months 
2-6 months 
10 weeks 
4 weeks 
10 weeks 
4 weeks 
10 weeks 
16 weeks 
4 weeks 
10 weeks 
16 weeks 
Minimum 
content 
Maximum 
content 
ppm (mg/kg) of complete 
feedingstuffs 
5 
5 
10 
5 
2 
>10 
^>10 
> 20 
> 20 
> 20 
> 20 
> 20 
> 20 
>20 
20 
20 
40 
20 
10 
25 
25 
50 
50 
50 
50 
50 
50 
50 
J 
OPINION OF THE COMMITTEE 
The Committee examined the specialized work on bacterial resistance in connection with macro-
lides and related products as also the recommendations from international organizations and 
regional advisory committees concerning the non-therapeutic use of antibiotics. In addition, 
twenty-five specialists in bacteriology, clinical microbiology, pharmacology, human and 
animal epidemiology and food hygiene had been consulted on the subject of the harr^ul effects 
for public health which might arise from the use of macrolides and related products ■in animal 
feeding. 
i: 
Although knowledge of the phenomena of bacterial resistance and their consequences for the 
environment appeared to be incomplete, the Committee endeavoured to reply as completely as 
possible to the questions posed by the Commission. 
1. All the macrolides and related products have analogous spectra of activity (*) and similar 
mechanisms of resistance. 
Studies carried out in vitro have shown that the majority of micro-organisms which are 
sensitive to these antibiotics may become resistant to them by spontaneous chromosomal 
mutation without previous contact with an antibiotic of the same group. The resistant 
strains have a prolonged reproduction time and an attenuated virulence. This type of re-
sistance is very rare and not transferable. 
In addition, it has been established by studies on resistant strains isolated in hospitals 
that bacteria could develop two types of cross resistance to macrolides and related pro-
ducts, due to modification of the ribosomes. These types of resistance have been descri-
bed as inducible and constitutive resistance. 
Inducible resistance has been observed solely with Staphylococcus aureus strains. It 
appears rapidly after contact of the micro-organism with very low doses of an inducer anti-
biotic and may affect simultaneously all the antibiotics of the same group. Among the 
macrolides and related products, erythromycin and oleandomycin have been shown to be power-
ful inducers. Lincomycin, tylosin, spiramycin and virginiamycin appear to be free from 
inducing properties. Inducible resistance is not stable. It disappears when the bacteria 
are subjected to prolonged culture without any contact with an antibiotic. 
Constitutive resistance has been observed essentially with saprophytic micro-organisms and 
certain pathogenic agents, particularly Staphylococcus aureus. It appears to result from 
heavy selection pressure (high dose) of one or other of the antibiotics of the group in-
volved and affects simultaneously all the antibiotics of the same group. This resistance 
is stable and does not disappear spontaneously. 
A transfer of resistance to macrolides and related products may also occur between bacteria 
which are sensitive to these antibiotics. This has been shown to be a transduction pheno-
menon via bacteriophages and not one of conjugation. 
Up to now, these resistance phenomena have not appeared in bacteria representative of the 
intestinal flora of farm animals (enterococci, saprophytical staphylococci) when macro-
lides and related products were used at nutritional levels in feedingstuffs. 
2. Available data show that these antibiotics, when used for nutritional purposes according 
to the conditions authorized by Community directives, contribute significantly to animal 
production by improving growth. The mode of action is through anabolic effects. 
3. The use of macrolides and related products in human therapy varies considerably from one 
Member State to another. Erythromycin appears to have the widest application. This anti-
biotic is used for the treatment of infectious diseases due to Gram-positive bacteria, 
mycoplasma or Haemophilus influenza and also in cases of resistance of pathogenic agents 
to other antibiotics or of allergy to penicillin. Lincomycin is indicated for the treat-
ment of diseases due to Bacteroides fragilis. In certain Member States, use is also made 
of oleandomycin in cases of resistance of pathogenic agents to other antibiotics or of 
allergy to penicillin, of spiramycin in stomatology and, on a very small scale, of virginia-
mycin. Only tylosin appears to have no medical use. 
(*) This activity covers, with individual variations, essentially Gram-positive and-negative 
cocci. Gram-positive bacilli, actinomycetes, corynebacteria, certain representatives of 
the bacteroid family and mycoplasma. The enterobacteria are insensitive to them in vivo. 
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In addition, with the exception of virginiamycin, all the macrolides and related products 
involved have applications in veterinary therapy. Tylosin and spiramycin are used for the 
treatment of dysentry in pigs; tylosin and erythromycin for the treatment of mycoplasmic 
respiratory diseases in pigs, calves and poultry. Oleandomycin and lincomycin are used 
essentially for the treatment of localized infections, such as mammitis or external otitis; 
erythromycin is also used for these indications. 
For the Community as a whole, the proportion of these antibiotics used in 1976 in therapy, 
expressed as % of the total therapeutic consumption of antibiotics, was as follows: 
Human Veterinary 
therapy therapy 
Tylosin - 6 
Virginiamycin <1 
Spiramycin 1 2 
Oleandomycin 1-2 1 
Lincomycin 2 1-2 
Erythromycin 5 2-3 
An exhaustive reply to the question raised would require the carrying out of systematic 
epidemiological studies on the transfer and behaviour of strains resistant to macrolides 
and related products in all the regions where these products are used therapeutically. 
Partial information available in this field together with knowledge gained about the 
mechanisms of resistance of certain micro-organisms to macrolides permits however some 
important conclusions to be drawn. 
According to enquiries made in the Federal Republic of Germany and in some other European 
countries during the period 1960-1975, the frequency of occurrence of strains of 
Staphylococcus aureus resistant to erythromycin isolated in hospitals, has remained con-
stant or decreased slightly despite a marked increase in the use of macrolides in animal 
nutrition. On the other hand, a study performed in Japan has shown an increase in this 
resistance since 1965. It should be noted, however, that no information was available on 
the conditions of use of macrolides in Japan. 
According to various studies, staphylococci resistant to macrolides and related products 
do not produce any cross resistance with other antibiotics or chemotherapeutics. In 
addition, the transfer of resistance to these products with staphylococci does not involve 
direct contact (conjugation) but intermediate bacteriophages (transduction). This means 
that, unlike mechanisms specific to other antibiotics, the transfer of resistances is 
largely restricted. This phenomenon is confirmed by the high Level of sensitivity to 
macrolides and related products at present found among pathogenic agents, particularly 
group A streptococci. 
Little is known about the development of resistance in other micro-organisms sensitive to 
macrolides (treponema, mycoplasma, bacteroides, haemophylus). 
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Whilst none of the data proved that the use of the antibiotics involved in animal nutri-
tion has interfered with therapeutic uses, the Committee felt that, in the absence of more 
adequate information on the resistance phenomena, it would be desirable to adopt a cautious 
attitude and to take measures to avoid the build-up of resistant strains as far as 
possible. 
In view of the therapeutic uses of erythromycin and lincomycin and also of the inducible 
resistance properties inherent in erythromycin and oleandomycin, it is proposed that : 
- the use of spiramycin, tylosin and virginiamycin in animal nutrition be continued in 
accordance with the conditions of use already authorized for these products by Community 
Directives, 
- to ask the manufacturers of spiramycin, tylosin and virginiamycin to pursue research on 
the development of strains resistant to these products in order that the Committee can 
re-evaluate them in three years time. 
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FIRST REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE CONDITIONS OF USE OF CERTAIN ANTIBIOTICS IN FEEDINGSTUFFS 
Opinion expressed 21 February 1978 
TERMS OF REFERENCE 
The Scientific Committee for Animal Nutrition was requested to examine the conditions of use 
of zinc bacitracin and flavophospholipol, authorized by Community Directives, and to give an 
opinion on the following questions. 
A. Use of zinc bacitracin and flavophospholipol in feedingstuff s for laying hens 
1. Has use of these antibiotics in feedingstuff s for laying hens a significant effect on 
egg production ? 
2. If so, is it to be considered as a nutritional, prophylactic or therapeutic action at 
the dose levels authorized (15-100 ppm (mg/kg) in complete feedingstuff s for zinc 
bacitracin ; 2-5 ppm (mg/kg) for flavophospholipol) ? 
3. Does the use of these antibiotics, under the conditions authorized, result in the 
presence of residues in eggs ? If so, what is the nature and the amount of these 
residues ? 
4. In the light of the answers to the abovementioned questions and the requirements of 
Article 6(2) of Council Directive 70/524/EEC concerning additives in feedingstuff s (1), 
should 
- the use of zinc bacitracin and/or flavophospholipol in feedingstuff s for laying hens 
be prohibited in Member States ? 
- the permitted conditions of use be modified ? 
B. Use of zinc bacitracin in feedingstuff s for young animals 
1. Do increased nutritional effects, free of prophylactic or therapeutic effects, result 
from the addition to complete feedingstuff s of dose levels of zinc bacitracin higher 
than 20 ppm (mg/kg) and not exceeding 50 ppm (mg/kg) (with the exception of milk 
replacers where a maximum content of 80 ppm (mg/kg) is permitted), when feeding 
- poultry, excluding ducks and geese, up to the age of 4 weeks, 
- swine up to the age of 10 weeks, 
- calves, lambs and kids up to the age of 16 weeks, 
- animals bred for fur ? 
2. Do these conditions of use result in the presence of residues in animal products ? If 
so, what is the nature and the amount of these residues ? 
(1) 0J N° L 270 of 14.12.1970, p. 1 
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3. Can they give rise to problems of bacterial resistance ? 
4. Are they acceptable for the environment ? 
5. Would a modification of the conditions of use indicated under item 1 to increase up to 
100 ppm (mg/kg) the maximum content of zinc bacitracin in complete feedingstuff s 
- for turkeys and chickens for fattening up to the age of 8 weeks, 
- for pullets up to point of laying, 
- for swine during the growing period 
result in a significant increase of nutritional effects, free of prophylactic or thera-
peutic effects, and/or result in modifying the answers to questions posed under items 
2, 3 or 4 ? 
6. In the light of the answers to the abovementioned questions and the requirements of 
Article 6(2) of Council Directive 70/524/EEC concerning additives in feedingstuff s (1), 
should 
6.1 conditions of use of zinc bacitracin indicated under item 1 for 
- poultry, excluding ducks and geese, 
- swine, 
- calves, lambs and kids, 
- animals bred for fur 
be maintained ? 
6.2 conditions of use for poultry, insofar as turkeys, chickens for fattening and pullets 
are concerned, and for swine be modified according to the conditions indicated under 
item 5 ? 
BACKGROUND 
In accordance with the provisions of Council Directive 70/524/EEC (1), of 23 November 1970, 
concerning additives in feedingstuff s, as last amended by the twenty first Commission 
Directive of 23 December 1977 (2), the use of zinc bacitracin and flavophospholipol is 
authorized at Community level under the following conditions set out in Annex I, Section A, 
of the Directive : 
(1) 0J N° L 270 of 14.12.1970, p. 1 
(2) 0J N° L 40 of 10. 2.1978, p. 19 
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Additive/Species of animal 
Zinc bacitracin 
Turkeys 
Other poultry, with the excep-
tion of ducks, geese, laying 
hens and pigeons 
Swine, calves, lambs 
and kids 
Animals bred for fur 
Flavophospholipol 
Turkeys 
Other poultry, with the 
exception of ducks, geese, 
laying hens and pigeons 
Swine 
Calves 
Animals bred for fur 
Maximum age 
26 weeks 
16 weeks 
6 months 
-
26 weeks 
16 weeks 
6 months 
6 months 
— 
Minimum 
content 
Maximum 
content 
ppm (mg/kg) of complete feedingstuffs 
5 
5 
5 
5 
1 
1 
1 
10 (*) 
6 
8 (*) 
2 
20 
20 
20 
80 (*) 
20 
20 
20 
20 
25 (*) 
16 
16 (*) 
4 
(*) Mi Ik replacers 
Furthermore, Member States are authorized to use, by way of derogation up to 31 December 1978, 
- zinc bacitracin and flavophospholipol in feedingstuffs for laying hens, 
- dose levels of zinc bacitracin exceeding the maximum permitted levels stated in Annex I, 
under the following conditions stated in Annex II, Section A, of the Directive : 
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Additive/Species of animal 
Zinc bacitracin 
Laying hens 
Poultry, with the 
exception of ducks, geese and 
laying hens 
Swine 
Calves, lambs and kids 
Animals bred for fur 
Flavophospholipol 
Laying hens 
Cattle for fattening 
Maximum age 
end of the 4th 
week 
end of the 10th 
week 
end of the 16th 
week 
-
r 
Minimum content 
ppm (mg/kg) of com 
15 
> 20 
? 20 
■? 20 
? 20 
2 
5 
Maximum 
content 
Diete feedingstuffs 
100 
50 
50 
50 
50 
5 
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Besides, the Commission was asked by a Member State to amend as follows the conditions of use 
of zinc bacitracin stated in Annex II, Section A : 
Species of animal 
Turkeys, chickens for 
fattening 
Pullets 
Other poultry 
Swine 
Calves, lambs, kids, 
animals bred for fur 
Maximum age 
8 weeks 
point of laying 
unchanged 
growing period 
unchanged 
Minimum 
content 
Maximum 
content 
ppm (mg/kg) of complete feedingstuffs 
> 20 
> 20 
unchanged 
>20 
unchanged 
100 
100 
unchanged 
100 
unchanged 
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OPINION OF THE COMMITTEE 
A. Use of zinc bacitracin and flavophospholipol in feedingstuff s for laying hens 
1. The addition of zinc bacitracin or flavophospholipol to feedingstuff s for laying hens 
can, under certain conditions, increase the output of eggs, particularly in the case of 
hens with a low level of egg production. It remains to be proved, however, that signi-
ficant results are obtained from strains with high levels of production and that the 
use of zinc bacitracin in concentrations exceeding 80 mg/kg feedingstuff is justified. 
Nevertheless, it has been established that these additives have a favourable effect on 
the animal organism and that they reduce mortality. 
2. At authorized dose-levels, both zinc bacitracin and flavophospholipol give improved 
utilization of dietary constituents and beneficial effects on the intestinal flora. 
For zinc bacitracin however, a concomitant bactericidal effect on some micro-organisms 
of the animal alimentary tract cannot be ruled out at concentrations higher than 
80 mg/kg feedingstuff. 
These additives have a limited antibacterial spectrum with no systemic action and no 
known effects on specific diseases of laying hens. 
3. Under the authorized conditions of use, zinc bacitracin and flavophospholipol are not 
absorbed in measurable amounts by the alimentary tract and, at the lower limit of 
analytical determination (*), no residues have been found in eggs. 
4. The Committee is of the opinion that there is no reason to prohibit the use in Member 
States of zinc bacitracin and/or flavophospholipol in feedingstuff s for laying hens. 
However, for the reasons mentioned in points 1 and 2, it is recommended 
- that the maximum content of zinc bacitracin in complete feedingstuffs be limited to 
80 mg/kg, and 
- that the manufacturers of these additives be required to continue to carry out studies 
with the view to determine both for flavophospholipol and zinc bacitracin the varia-
tion of egg production in relation to the dose-level of additive, the composition of 
the diet and the mode of feeding, the genetic quality of the breeds and strains of 
laying hens as well as the conditions under which they are reared. The results ob-
tained should be presented with all details of the experimental procedures applied. 
A reassessment could subsequently be made in the light of the results of this work. 
B. Use of zinc bacitracin in feedingstuff s for young animals 
1. Improved growth can result when zinc bacitracin at levels between 20 and 50 mg/kg of 
complete feedingstuffs (or between 20 and 80 mg/kg in milk replacers) is given to : 
- poultry (excluding ducks and geese) up to the age of 4 weeks, 
- swine up to the age of 10 weeks, 
- calves, lambs and kids up to the age of 16 weeks, 
- animals bred for fur. 
This response to the antibiotic is considered to be nutritional and without prophy-
lactic or therapeutic effects. 
(*) zinc bacitracin : 0.1 mg/kg for egg yolk 
0.05 mg/kg for albumen 
flavophospholipol : 0.07 mg/kg for egg yolk 
0.01 mg/kg for albumen 
2. Zinc bacitracin is not absorbed in measurable quantities from the alimentary tract and, 
at the lower limit of analytical determination (0.05 - 0.1 mg/kg), no residues have 
been found in food products of animal origin when the antibiotic is given in feeding-
stuffs at authorized levels. 
3. At these levels there have been no indications of problems of bacterial resistances. 
4. The use of zinc bacitracin at authorized levels is not considered detrimental to the 
environment. When excreted in animal faeces the product is degraded in dung and soil 
within a few weeks and, if much water is present, within a few days. 
5. For 
- turkeys and chickens for fattening up to the age of 8 weeks, 
- pullets up to the point of laying, 
- swine during the growing period, 
experimental evidence is lacking that an increase of zinc bacitracin up to a level of 
100 mg/kg in complete feedingstuff s results in a significant increase in nutritional 
effects. Furthermore, there is little information on the effects of these levels on 
the gut flora and on the bacterial resistances. 
6. The Committee is of the opinion that the permitted conditions of use of zinc bacitracin 
indicated under item 1 should be maintained. 
An increase of the dose-levels, as indicated in the Commission's question N° Β 5, 
could be envisaged only if statistically controlled data were available on the effects 
of these levels on 
- animal production, and 
- bacterial resistances after long-term feeding, 
as well as information on the degradation in dung and soil of the amounts excreted. 
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SECOND REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE CONDITIONS OF USE OF CERTAIN ANTIBIOTICS IN FEEDINGSTUFFS 
Use of zinc bacitracin and flavophospholipol in feedingstuff s for laying hens 
Opinion expressed 11 October 1978 
In its opinion expressed on 21 February 1978, the Committee, taking into account the avail-
able documentation, agreed that the use of flavophospholipol or zinc bacitracin in feeding-
stuffs for laying hens while producing zootechnie improvements did not result in hazards for 
the consumer. 
However, it recommended 
- that the maximum content of zinc bacitracin in complete feedingstuff s for laying hens be 
limited to 80 mg/kg, and 
- that the manufacturers of these additives be required to furnish complementary information. 
From this further information it appeared that, due to selection, use of hybrids, improvement 
in quality of rations and breeding techniques, there has been improvement in feed efficiency 
of laying hens associated with reduced feed intake. This phenomenon, which is independent 
of the effect of additives, results in a reduction of the amount of additives consumed with 
the ration. 
In these conditions, the Committee is of the opinion that the use for laying hens of flavo-
phospholipol to the extent of 2 to 5 mg/kg complete feedingstuffs or of zinc bacitracin to 
the extent of 15 to 100 mg/kg complete feedingstuff s is acceptable. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE EFFECTS OF NITRATES IN FEEDINGSTUFFS 
Opinion expressed 19 April 1978 
TERMS OF REFERENCE 
The Scientific Committee for Animal Nutrition was requested to give an opinion on the follow-
ing questions : 
1. What are the normal contents of nitrates in milk, milk powder and powdered whey ? 
2. What are the maximum intakes of nitrates acceptable for animal species, in particular, 
cattle ? 
3. What are the levels of nitrates, nitrites and nitrosamines which could result in products 
of animal origin from absorption by animals of feedingstuff s containing normaL and in-
creased levels of nitrates ? 
4. In the light of the answers to the abovementioned questions, should maximum contents be 
fixed for nitrates in 
- straight feedingstuff s and, in particular, milk powder and powdered whey ? 
- complete feedingstuff s and, in particular, milk feeds ? 
BACKGROUND 
As the presence of nitrates at dose-levels normally found in feedingstuff s was considered 
harmless to animals and, indirectly, to man, these products were not made subject to limita-
tions in Council Directive 74/63/EEC of 17 December 1973 concerning the fixing of maximum 
permitted levels for undesirable substances and products in feedingstuff s (1). 
In July and August 1976, one Member State, since it considered that nitrates were not free of 
health risks, took successively various measures intended to limit the nitrate content in 
whole milk, skimmed milk powder and powdered whey. 
Since the decision must be taken at Community level whether these measures are justified or 
must be rescinded, the Commission deemed it necessary to ask the Scientific Committee for 
Animal Nutrition a series of questions, the answers of which it felt were essential to 
clarify the situation. 
OPINION OF THE COMMITTEE 
The Committee has examined the available information on nitrate toxicity and the presence of 
nitrates in animal feedingstuffs. It has observed numerous gaps in this documentation and 
felt that, in the absence of additional data, it was difficult to assess the risks resulting 
from the presence of nitrates in feedingstuff s and to answer the Commission's questions. 
(1) OJ N° L 38 of 11.2.1974, p. 31 
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In order to obviate these difficulties, it appeared necessary to have available results of 
analytical checks carried out on milk products in the Member States and to pursue experi-
mental studies on the effects of nitrates on piglets and calves. To this end, trials were 
undertaken at the end of 1976 in the departments of two Members of the Committee and also in 
the Netherlands at the Instituut voor Landbouwkundig Onderzoek van Biochemische Produkten 
(ILOB at Wageningen) and at the Laboratory of Chemical Analysis of Foodstuffs of the National 
Institute of Public Health at Bilthoven. 
The Committee considered it essential to wait until these experiments were completed and full 
reports available before voicing its conclusions. The answers to the Commission's questions 
are given below. 
1. According to results of checks performed in 1976 and 1977 in the Member States, the nitrate 
contents of milk products were in the following ranges : 
fresh milk : <0.1 - 3.1 mg N0~/kg. 
skimmed milk powder : - normally : <10 - 50 mg NO,/kg; 
- occasionally contents exceeding 50 mg/kg and reaching up to 
440 mg/kg were noted. 
powdered whey : 20 - 2700 mg N0,/kg with a maximum frequency occuring at 400 mg/kg. 
It should be noted that high concentrations of nitrates in powdered whey result, in general, 
from cheese-making processes using added nitrates. The presence of nitrates in concentra-
tions above 50 mg N0,/kg in skimmed milk powder can be considered indicative of poor 
quality resulting from faulty production or adulteration. 
Furthermore, the possibility cannot be ruled out that variations in the results from dif-
ferent sources are, to some extent, due to the various analytical techniques used. 
2. The sensitivity of the animals to nitrates varies according to species, age, composition of 
ration and rearing conditions. Although the available information is not complete enough 
to permit an assessment of toxicity thresholds, it has been observed that most livestock 
animals tolerate high levels of nitrates, which may reach 5,000 mg N0,/kg of dry matter in 
the case of green fodder. 
With regard to veal, trials conducted in France with two lots of 16 animals showed that a 
daily intake of nitrates of 50 to 60 mg NO,/kg of ration for six weeks followed by 18 to 
25 mg/kg of_ration for ten weeks (the water for preparation of the ration having a content 
of 50 mg NO,/kg) had no influence on growth pattern, biochemical parameters of the blood 
or hepatic reserve in vitamin A. Experiments in the Netherlands on 60 calves aged between 
10 and 18 weeks confirmed the high tolerance of cattle to nitrates. 
Daily administration of nitrates for eight weeks at dose-levels of 400, 2,000, 5,000 and 
10,000 mg NO,/kg of milk replacer respectively had no effect on growth pattern, weight in-
crease, food conversion rate, quality of carcass and biochemical parameters of the blood. 
Histopathological examination of the liver and the kidneys was negative. It was also estab-
lished that the presence or absence of antibiotics in the ration had no influence on the 
results. 
Piglets alone appear to be sensitive under certain conditions. In experiments performed 
in Germany, it has been observed on new-born animals removed from the mother that daily 
intake of nitrates caused a slight increase in the methaemoglobin content of the blood 
where dose-levels exceeded 400 mg NO,/kg of milk replacer ; the other biochemical or 
physiological parameters were unaffected. The phenomenon was however revealed to be re-
versible (the methaemoalobin content returning to normal after three to four weeks despite 
continuous administration of the nitrates) and had no effect on growth. 
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3. The normal contents of nitrates in milk were given under item 1. The nitrite contents 
appear generally less than 0.3 mg N0?/kg of fresh milk and the N-nitrosamine contents be-
low the detection limit (0.1 /jg/kg of fresh milk). 
A significant increase in the nitrate content of milk appears only when high doses of 
nitrates are absorbed by the cow. Concentrations of 13 to 20 mg NO /kg have been recorded 
in fresh milk in cases where the quantity of nitrates absorbed had caused intoxication 
(dose-levels of the order to 600 mg N0~/kg of live weight). 
At the end of the experiments conducted on calves in the Netherlands (see under item 2), 
the nitrate, nitrite and N-nitrosamine contents were determined in various tissues of the 
trial animals. The average nitrate contents were as follows : 
\ . NO, content in 
\ . the ration 
X^mg/kg) 
NO, content\. 
in wet tissues^v 
(mg/kg) \ . 
Muscle 
Liver 
Kidney 
Blood 
18 
(control) 
2 
8 
4 
2 
400 
5 
16 
13 
11 
2.000 
25 
22 
44 
53 
5.000 
30 
34 
92 
115 
10.000 
65 
65 
182 
245 
The nitrite contents (of the order of 1 mg N0?/kg of wet tissue) appeared constant in all 
tissues and for all groups of animals and unconnected with the amounts of nitrates inges-
ted. 
Determination of N-nitrosamines by highly specific methods showed the presence of traces 
of these products (always below 1 /jg/kg of wet tissue) in the tissues of both the control 
and treated animals. As with nitrites there was no correlation with the amount of 
nitrates ingested. 
According to present scientific knowledge, normal levels of nitrates found in feedingstuff s 
do not involve risks for animals. 
High levels of nitrates, which may reach 5,000 mg NO,/kg of feedingstuff are generally well 
tolerated by livestock. Only piglets appear, under certain conditions, to be sensitive. 
In this regard, it has been observed that, in new-born piglets separated from their mothers, 
the administration of nitrates at dose-levels higher than 400 mg NO,/kg of milk replacer 
resulted in a slight modification of the methaemoglobin content of the blood. This modi-
fication appeared, however, to be temporary (the methaemoglobin content reaching the 
normal level after three or four weeks, despite the continuous administration of nitrates 
in the ration) and without effect on the health of the animal. 
Moreover, on the basis of data available on calves, continuous administration of nitrates, 
even at high levels, does not result in the presence of nitrites or nitrosamines in 
animal products. 
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